In our GBM mouse models, elevated SOX2 expression enhances HCMV’s oncomodulatory effects, suggesting that combinatorial expression profiling of IE1 and SOX2 may have prognostic value in patients with gliomas. This evidence concerns the gene SOX2 and central nervous system cancer.